Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(1):1-2
At the 73rd General Assembly, in 2020, the World Health Organization (WHO) approved the adoption of the “Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem,” based on the guarantee of the three following pillars: 1) that 90% of girls up to 15 years of age receive the vaccine against human papillomavirus (HPV); 2) that 70% of women perform a screening with HPV testing at 35 and 45 years old; and 3) that 90% of women identified with precursor lesions or invasive cancer receive treatment.
Cervical cancer is a preventable, curable disease with high morbidity and mortality among women in countries without organized prevention programs, like Brazil. Globally, more than 570,000 new cases emerge annually, and more than 311,000 women die each year. According to the WHO, most of these deaths occur in countries with low development rates. In Brazil, cervical cancer ranks 3rd among malignant neoplasms in women, with 15.43 cases per 100,000 women per year, and 4th in mortality.
[…]
Search
Search in:
At the 73rd General Assembly, in 2020, the World Health Organization (WHO) approved the adoption of the “Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem,” based on the guarantee of the three following pillars: 1) that 90% of girls up to 15 years of age receive the vaccine against human papillomavirus (HPV); 2) that 70% of women perform a screening with HPV testing at 35 and 45 years old; and 3) that 90% of women identified with precursor lesions or invasive cancer receive treatment.
Cervical cancer is a preventable, curable disease with high morbidity and mortality among women in countries without organized prevention programs, like Brazil. Globally, more than 570,000 new cases emerge annually, and more than 311,000 women die each year. According to the WHO, most of these deaths occur in countries with low development rates. In Brazil, cervical cancer ranks 3rd among malignant neoplasms in women, with 15.43 cases per 100,000 women per year, and 4th in mortality.
[...]
Comments